Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02590497

Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery

The Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Ohio State University Comprehensive Cancer Center · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This pilot clinical trial studies the correlation between the genetics and brain images of patients with newly diagnosed glioblastoma before surgery. The genetic characteristics of a tumor are an important way to predict how well it will respond to treatment. Imaging, using magnetic resonance imaging (MRI), takes detailed pictures of organs inside the body, and may also provide information that helps doctors predict how brain tumors will respond to treatment. If MRI can provide doctors with similar information about the tumor as the tumor's genes, it may be able to be used to predict tumor response in patients whose tumors cannot be reached by surgery or biopsy to get tissue samples.

Detailed description

PRIMARY OBJECTIVES: I. Determine the correlation between the genetic and neuroimaging signature of glioblastoma. II. Determine the correlation between the neuroimaging signature of glioblastoma and prognosis. OUTLINE: Patients undergo MRI before and after gadolinium contrast administration, including 3-dimensional (3D) volumetric T1-weighted sequence, fluid attenuated inversion recovery (FLAIR) sequence, diffusion weighted imaging, and perfusion MRI. Tissue samples are also analyzed for the tumor genetic profile.

Conditions

Interventions

TypeNameDescription
PROCEDUREDiffusion Weighted ImagingUndergo diffusion weighted MRI
DRUGGadoliniumUndergo gadolinium-enhanced MRI
OTHERLaboratory Biomarker AnalysisTissue genetic analysis
PROCEDUREMagnetic Resonance ImagingUndergo gadolinium-enhanced MRI
PROCEDUREMagnetic Resonance ImagingUndergo 3D volumetric T1-weighted sequence
PROCEDUREMagnetic Resonance ImagingUndergo FLAIR sequence
PROCEDUREPerfusion Magnetic Resonance ImagingUndergo perfusion MRI

Timeline

Start date
2016-03-20
Primary completion
2017-10-26
Completion
2017-10-26
First posted
2015-10-29
Last updated
2018-01-31

Source: ClinicalTrials.gov record NCT02590497. Inclusion in this directory is not an endorsement.